What is Elutia Inc. (ELUT) stock price today?

Elutia Inc. (ELUT) currently trades at $1.00 per share. The stock has a market capitalization of $49.82M and a P/E ratio of —x.

Is ELUT stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Elutia Inc. has a Smart Value Score of 41/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Elutia Inc.'s revenue and earnings?

Elutia Inc. has trailing twelve-month (TTM) revenue of $12.29M with profit margins of 434.20%. Earnings per share (EPS) is $-0.64.

Is ELUT stock overvalued or undervalued?

Based on our DCF model, Elutia Inc.'s intrinsic value is $1.31, representing a margin of safety of 31.28%. The stock currently trades at a P/E of —x.

ELUT

Elutia Inc.

NASDAQ: ELUT · HEALTHCARE · MEDICAL DEVICES

$1.00

+0.00% today

Updated 2026-04-29

Market cap

$49.82M

P/E ratio

—

P/S ratio

4.05x

EPS (TTM)

$-0.64

Dividend yield

—

52W range

$1 – $3

Volume

0.1M

Market cap

$49.82M

P/E ratio

—

P/S ratio

4.05x

EPS (TTM)

$-0.64

Dividend yield

—

52W range

$1 – $3

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

4.7

Growth

5.0

Quality

C+

4.5

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$5.00

+400.00%

12-Month target

—

Intrinsic (DCF)

$1.31

Margin of safety

+31.28%

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Profit margin 434.20% — above average

+ Revenue growth 16.20% QoQ

+ 31.28% below intrinsic value

Risks

- Negative free cash flow $-25.21M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$23.85M	$24.75M	$24.38M	$12.29M	$12.29M
Net income	$-32.90M	$-37.66M	$-53.95M	$53.38M	$70.79M
EPS	—	—	—	—	$-0.64
Free cash flow	$-21.97M	$-22.11M	$-23.31M	$-46.69M	$-25.21M
Profit margin	-137.94%	-152.18%	-221.33%	434.23%	434.20%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ELUT	$49.82M	41	4.7	4.5	6.7	5.0	+31.28%	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Elutia Inc. trades at $1.00. Our Smart Value Score of 41/100 indicates the stock is fair. TTM revenue stands at $12.29M. with profit margins at 434.20%. Our DCF model estimates intrinsic value at $1.31.

Frequently asked questions

What is Elutia Inc.'s stock price?

Elutia Inc. (ELUT) trades at $1.00.

Is Elutia Inc. overvalued?

Smart Value Score 41/100 (Grade D, Sell). DCF value $1.31.

What is the price target of Elutia Inc. (ELUT)?

The analyst target price is $5.00, representing +400.0% upside from the current price of $1.00.

What is the intrinsic value of Elutia Inc. (ELUT)?

Based on our DCF model, intrinsic value is $1.31, a +31.3% margin of safety versus $1.00.

What is Elutia Inc.'s revenue?

TTM revenue is $12.29M.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio4.05x

ROE—

Beta0.71

50D MA$1.11

200D MA$1.17

Shares out0.04B

Float0.02B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ELUT vs LLY →ELUT vs JNJ →ELUT vs ABBV →Stock screener →